Baqsimi (nasal glucagon), rescue treatment for severe hypoglycaemia now covered in British Colombia, Alberta & Saskatchewan

27 April 2022 - Lilly Canada is pleased to announce that as of 5 April 2022, Baqsimi (glucagon nasal powder) ...

Read more →

Astellas announces reimbursement for Xospata (gilteritinib) in most provinces for patients with relapsed or refractory acute myeloid leukaemia with a FLT3 mutation

21 April 2022 - Having access to an additional treatment option offers hope for Canadian adult AML patients with relapsed ...

Read more →

Teva Canada welcomes public drug plan reimbursement by Alberta, Saskatchewan, Québec, Veteran Affairs Canada and the non-insured health benefits program for patients prescribed Ajovy (fremanezumab) for the preventive treatment of migraine in adults

2 March 2022 - Public formulary and program coverage makes AJOVY® accessible to more migraine patients across Canada. ...

Read more →

AbbVie announces provincial reimbursement for Venclexta (venetoclax) with obinutuzumab for patients with previously untreated chronic lymphocytic leukaemia in Alberta, Saskatchewan, British Columbia and Manitoba

24 February 2022 - AbbVie announced today that Alberta, Saskatchewan, British Columbia, and Manitoba now reimburse Venclexta (venetoclax) in combination ...

Read more →

AbbVie announces first provincial reimbursements for Venclexta (venetoclax) in combination with azacitidine for acute myeloid leukaemia patients

10 February 2022 - Following the signing of an agreement between AbbVie and the pan-Canadian Pharmaceutical Alliance, Quebec, Saskatchewan, and ...

Read more →

'Equity issue:' Saskatchewan to fully cover cost of abortion drug Mifegymiso

7 June 2019 - Advocates are celebrating the Saskatchewan government's decision to fully fund the cost of the abortion drug ...

Read more →

'I took it for my family': Accepting risks of multiple sclerosis drug a part of Sask. couple's love story

3 May 2019 - Sask. just announced it will fund a drug that may relieve rapid degeneration caused by MS. ...

Read more →

SMA patients in Saskatchewan, Canada, gain wider access to Spinraza

1 May 2019 - The Canadian province of Saskatchewan has joined that of Quebec in granting access to Spinraza (nusinersen) ...

Read more →

Sask. woman calls on government to cover cystic fibrosis drug

4 August 2017 - A Beauval, Sask. woman wants the Canadian government to cover an expensive drug for her cystic ...

Read more →

Canada reaches health funding agreement with Saskatchewan

17 January 2017 - Canada's public healthcare system is a source of pride. The Government of Canada and the Government ...

Read more →

Saskatchewan includes Lemtrada (alemtuzumab) on MS Drugs Program for eligible patients

5 July 2016 - Unique treatment delivered in only two cycles one year apart. ...

Read more →